Cochlear to defend shareholder class action over 2026 profit forecast

By Reuters News

Sept 29 (Reuters) - Australian hearing implant maker Cochlear COH.AX said on Tuesday it has been served with a shareholder class action in the Supreme Court of Victoria over its fiscal 2026 underlying net profit forecast.

The company has denied the allegations outlined in the claim, and said it would defend the proceedings.


Here are some details:

  • On April 22, Cochlear slashed its 2026 underlying net profit forecast to A$290 million to A$330 million, citing weak trading conditions and uncertainty stoked by the Middle East war.

  • The cut had then triggered a 40.7% plunge in Cochlear shares.

  • Before the forecast cut, the company had reiterated that profit was tracking toward the lower end of its A$435 million-A$460 million range.

  • The claim was brought on behalf of investors who acquired interests in Cochlear shares between August 15, 2025 and April 21, 2026, the company said.

  • Cochlear did not immediately respond to a Reuters request seeking details of the allegations.

  • In mid-August, Sydney-based Cochlear reported underlying net profit of A$322.4 million for 2026.



($1 = 1.4255 Australian dollars)

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.